No Data
Synaptogenix | 10-Q: Q3 2024 Earnings Report
Express News | Synaptogenix Files for Prospectus Related to Resale or Other Disposition From Time to Time of up to 11.9 Mln Shares of Common Stock- SEC Filing
Telesis Bio TBIO Delisting; Synaptogenix SNPX Offering
Synaptogenix Enters Into Securities Purchase Agreements For A $5M Financing With Existing Investors Involving The Sale Of 5,000 Shares Of Its Newly Issued Series C Convertible Preferred Stock, With A Stated Value Of $1,000 Per Share; The Shares Of...
Express News | Synaptogenix Announces $5.0 Million Financing
12 Health Care Stocks Moving In Monday's Pre-Market Session
No Data
No Data
